Since we do not have access to a CDK inhibitor-treated breast cancer cohort containing gene expression and treatment response data, we examined CDK inhibitor drug sensitivity data in the Cancer Cell Line Encyclopedia [55] for five ER-positive/HER2-negative human breast cancer cell lines. This evidence concerns the gene ESR1 and breast carcinoma.